🔍

MAXIND - Max India Ltd

📊 NSE: MAXIND 🏢 Finance & Investments 📅 Last Updated: 12/14/2025 9:41

📢 Recent Corporate Announcements

Max India Appoints Former McKinsey Senior Partner Mrinalini Mirchandani as Independent Director

🟢 POSITIVE ⭐ 7/10

MANAGEMENT 📅 09 Apr 2026, 05:53 PM

Max India Limited has announced the appointment of Ms. Mrinalini Mirchandani as an Independent Director for a five-year term effective April 15, 2026. Ms. Mirchandani was the first woman Senior Partner at McKinsey & Company in India, where she led the Private Equity and Healthcare practices. Her extensive background includes leadership roles at Merrill Lynch and Egon Zehnder, specializing in M&A, capital raising, and growth strategy. This high-profile appointment is expected to significantly strengthen the board's strategic oversight and corporate governance.

Appointment of Ms. Mrinalini Mirchandani as Independent Director for a 5-year term until April 14, 2031.
Brings over 20 years of experience, including a tenure as Senior Partner at McKinsey & Company leading the Private Equity Practice.
Expertise includes Healthcare and Consumer Investment Banking from previous roles at Merrill Lynch.
Educational background includes an MBA from IIM Calcutta and recognition in the Economic Times 40 under Forty list.
The appointment is subject to shareholder approval and follows a recommendation by the Nomination and Remuneration Committee.

💡 Investors should view this as a positive development that enhances the board's expertise in healthcare and strategic growth. No immediate action is required, but the addition of such high-caliber talent supports the company's long-term governance and expansion goals.

Max India Appoints Former McKinsey Senior Partner Mrinalini Mirchandani as Independent Director

🟢 POSITIVE ⭐ 7/10

MANAGEMENT 📅 09 Apr 2026, 05:50 PM

Max India Limited has appointed Ms. Mrinalini Mirchandani as an Additional Independent Director for a five-year term starting April 15, 2026. Ms. Mirchandani brings elite strategic experience as the first female Senior Partner in McKinsey India's history, where she led the Private Equity and Healthcare practices. Her background includes significant expertise in M&A, capital raising, and growth strategy from her time at Merrill Lynch and Egon Zehnder. This high-profile appointment is expected to provide strong strategic oversight for Max India's business interests.

Appointment of Ms. Mrinalini Mirchandani as Independent Director for a 5-year term until April 14, 2031.
First woman to be elected Senior Partner in McKinsey’s 34-year history in India.
Extensive experience leading Private Equity and Healthcare practices at McKinsey and Merrill Lynch.
Recognized as one of Economic Times' '40 under Forty' Young Business Leaders in 2018.
Holds an MBA from IIM Calcutta and a B.Com from Mumbai University.

💡 Investors should view this as a positive governance and strategic move that brings top-tier consulting and healthcare expertise to the board. No immediate action is required, but the appointment strengthens the company's leadership for future growth phases.

Max India Appoints Former McKinsey Senior Partner Mrinalini Mirchandani as Independent Director

🟢 POSITIVE ⭐ 6/10

MANAGEMENT 📅 09 Apr 2026, 05:36 PM

Max India Limited has appointed Ms. Mrinalini Mirchandani as an Independent Director for a five-year term starting April 15, 2026. Ms. Mirchandani brings over two decades of high-level experience, having served as the first woman Senior Partner at McKinsey & Company in India, where she led the Private Equity and Healthcare practices. Her background also includes investment banking at Merrill Lynch and leadership roles at Egon Zehnder. This appointment is expected to provide the company with significant strategic oversight in growth, M&A, and capital raising.

Appointment of Ms. Mrinalini Mirchandani as Independent Director for a 5-year term effective April 15, 2026.
Ms. Mirchandani was the first woman Senior Partner in McKinsey India's 34-year history.
Expertise includes leading Private Equity and Healthcare practices at McKinsey and Investment Banking at Merrill Lynch.
Educational credentials include an MBA from IIM Calcutta and recognition in ET's 40 under Forty list (2018).

💡 This is a positive governance move that adds significant strategic depth to the board. Investors should monitor how her expertise in healthcare and M&A influences Max India's long-term growth strategy.

Max India Subsidiary Launches India's First Smart Adult Diaper Pants with 12-Hour Protection

🟢 POSITIVE ⭐ 6/10

EXPANSION 📅 31 Mar 2026, 10:49 AM

Max India's wholly-owned subsidiary, Antara Assisted Care Services, has launched a proprietary adult diaper under the AGEasy brand featuring 'Smart Liquid Distribution™' technology. The product is currently awaiting a patent grant and offers up to 12 hours of protection, targeting the growing senior care market in India. Since its inception in 2023, the AGEasy brand has already reached over 6.5 lakh seniors, demonstrating strong market penetration. This launch is part of Max India's strategy to build a comprehensive senior care ecosystem including residences, care homes, and consumer products.

Launched India's first adult diaper with proprietary Smart Liquid Distribution™ technology, currently awaiting patent grant.
Product provides up to 12 hours of protection and features an anti-bacterial core and wetness indicator.
AGEasy brand has touched over 6.5 lakh lives since its launch in 2023.
Antara Senior Care operates 8 facilities with 485 beds across Gurugram, Noida, Bengaluru, and Chennai.

💡 Investors should monitor the scaling of the AGEasy consumer product vertical as it represents a high-margin, scalable addition to Max India's service-heavy senior care portfolio. Success in proprietary product launches could significantly improve the company's overall valuation multiples.

Max India Subsidiary Files Rectification for Rs 31.53 Crore Income Tax Demand

🟡 NEUTRAL ⭐ 5/10

LEGAL 📅 30 Mar 2026, 03:29 PM

Max India's step-down subsidiary, Antara Purukul Senior Living Limited (APSLL), has received an income tax demand of Rs 31.53 Crore for the assessment year 2024-25. The company states that the demand resulted from clerical errors, specifically the non-consideration of brought forward losses and other tax attributes. APSLL has filed a rectification application and expects the final tax liability to be NIL once these attributes are applied. The company is also in the process of filing an appeal with the Commissioner of Income Tax (Appeals) as a precautionary measure.

Income Tax Department raised a demand of Rs 31.53 Crore against subsidiary APSLL for AY 2024-25.
Company claims the demand is due to non-consideration of brought forward losses and eligible tax attributes.
Rectification application filed on March 30, 2026, seeking to reduce tax liability to NIL.
Management expects no material financial impact on the company's financial statements.
Parallel legal action being taken via an appeal to the Commissioner of Income Tax (Appeals).

💡 Investors should monitor the outcome of the rectification application to confirm the demand is vacated. Since management expects zero liability, this is currently a procedural matter with low immediate risk.

Max India Announces Trading Window Closure from April 1, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 27 Mar 2026, 12:22 PM

Max India Limited has informed the stock exchanges that its trading window will be closed starting April 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the announcement of audited financial results for the quarter and year ending March 31, 2026. The restriction applies to all designated persons and their immediate relatives. The window is scheduled to reopen 48 hours after the financial results are officially declared.

Trading window closure begins on Wednesday, April 1, 2026.
Closure is related to the audited financial results for the quarter and year ending March 31, 2026.
Restriction applies to all designated persons and their immediate relatives.
The window will remain closed until 48 hours after the results are announced to the stock exchanges.

💡 This is a routine regulatory announcement with no impact on company fundamentals; investors should monitor the upcoming financial results for actual performance data.

Max India's Antara Noida Care Home Becomes First in City to Get NABH Accreditation

🟢 POSITIVE ⭐ 4/10

OTHER 📅 27 Mar 2026, 11:04 AM

Max India's wholly-owned subsidiary, Antara Senior Care, has received NABH accreditation for its 53-bed Noida facility, making it the first in the city to achieve this quality standard. This is the second facility in Antara's network to be accredited, following its Gurugram home in 2025. The company currently operates a total of 8 facilities with 485 beds across Gurugram, Noida, Bengaluru, and Chennai. This certification validates Antara's operational excellence in the fragmented senior care market, which is poised for growth as India's senior population is projected to reach 350 million by 2050.

Antara Noida (Sector 66) is the first senior care facility in the district to receive NABH Care Home Accreditation.
The Noida facility operates 53 beds offering short, medium, and long-term assisted living solutions.
Antara's total assisted care footprint now spans 8 facilities with 485 beds across four major Indian metros.
The accreditation covers critical parameters including resident safety, clinical governance, and infection control.
India's 80+ population is projected to grow by 279% by 2050, driving demand for standardized senior care infrastructure.

💡 Investors should recognize this as a key brand-differentiation milestone that strengthens Max India's position in the premium senior care segment. Monitor the company's progress in scaling these accredited facilities to drive higher occupancy rates and long-term value.

Max India Completes Registered Office Shift from Maharashtra to Delhi

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 26 Mar 2026, 08:21 PM

Max India Limited has successfully completed the relocation of its registered office from the State of Maharashtra to the National Capital Territory of Delhi. The Registrar of Companies, Delhi, approved and registered the change on March 25, 2026. As a result, the company's Corporate Identity Number (CIN) has been updated to L74999DL2019PLC464953. This administrative move follows the company's previous board and regulatory intimations made in late 2025 and early 2026.

Registered office shifted from Maharashtra to Max House, Okhla, New Delhi effective March 25, 2026
Corporate Identity Number (CIN) changed to L74999DL2019PLC464953
Approval received from the Registrar of Companies, Delhi, following the Regional Director's order
Updated Memorandum and Articles of Association (MoA & AoA) have been made available on the company website

💡 No action is required from investors as this is a routine administrative change. Shareholders should note the new address for any future physical correspondence with the company.

Max India Subsidiary Receives Rs 31.53 Crore Income Tax Demand

🔴 NEGATIVE ⭐ 6/10

REGULATORY 📅 25 Mar 2026, 08:00 PM

Max India's step-down subsidiary, Antara Purukul Senior Living Limited, has received an assessment order for the assessment year 2024-25. The Income Tax Department has raised a significant tax demand amounting to Rs. 31.53 Crore under Section 143(3) of the Income Tax Act. The company has stated that there are apparent mistakes in the assessment record and intends to file a rectification petition. Furthermore, the subsidiary will challenge the additions by filing an appeal before the relevant appellate authority.

Tax demand of Rs. 31.53 Crore raised against step-down subsidiary Antara Purukul Senior Living Limited.
Order issued by the Income Tax Department under Section 143(3) for Assessment Year 2024-25.
Company to file a rectification petition citing mistakes apparent from the assessment record.
Subsidiary intends to file a formal appeal against all additions made in the assessment order.

💡 Investors should monitor the outcome of the rectification petition and the subsequent appeal process, as this demand represents a potential contingent liability. While the company is contesting the order, any unfavorable final ruling could impact the consolidated financial position.

Max India Shareholders Approve Chairman Compensation and Key Related Party Transactions

🟡 NEUTRAL ⭐ 6/10

ROUTINE 📅 23 Mar 2026, 04:49 PM

Max India Limited has announced the successful passage of seven resolutions via postal ballot, including the approval of compensation for Non-Executive Chairman Mr. Analjit Singh for FY 2026-27. Shareholders also approved amendments to the 2020 Employee Stock Option Plan (ESOP) and the extension of these options to subsidiary employees. Additionally, several material related party transactions (RPTs) involving Antara Senior Living and Max Estates Gurgaon entities were cleared for FY 2025-26 and FY 2026-27. The voting results showed strong promoter support, with all resolutions passing with the requisite majority.

All 7 resolutions, including special resolutions for ESOP amendments and Chairman compensation, were passed by shareholders.
Compensation for Mr. Analjit Singh for FY 2026-27 was approved with 88.62% of total votes cast in favor.
Shareholders approved material Related Party Transactions (RPTs) between Antara Senior Living and Max Estates Gurgaon entities for FY 2026-27.
Amendments to the Employee Stock Option Plan 2020 and grants to subsidiary employees received high approval ratings of over 99.7%.
Total voting participation stood at approximately 63.32% of the total equity shares held by 38,899 shareholders.

💡 Investors should monitor the scale of Related Party Transactions to ensure they are conducted at arm's length and do not impact minority shareholder value. The approval of ESOPs for subsidiary employees suggests a strategic focus on talent retention within the company's core growth verticals.

Max India to Participate in DAM Capital Hospitals & Diagnostics Conference on March 23, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 18 Mar 2026, 11:55 AM

Max India Limited has scheduled an interaction with institutional investors at the DAM Capital Hospitals & Diagnostics Conference 2026. The event will take place on March 23, 2026, in Mumbai, starting at 10:00 am. The management will participate in both 1x1 and group meetings to discuss the company's performance based on publicly available information. No unpublished price sensitive information is expected to be disclosed during these sessions.

Investor meeting scheduled for March 23, 2026, starting at 10:00 am.
Participation in the DAM Capital Hospitals & Diagnostics Conference 2026 in Mumbai.
Format includes both 1x1 and group meetings with institutional investors.
Discussions will be strictly limited to publicly available information with no UPSI disclosure.

💡 Investors should monitor the company's website or exchange filings for any new investor presentations that may be released following the conference. As this is a routine investor interaction, no immediate action is required.

Max India to Participate in Arihant Capital Conference on March 11, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 02 Mar 2026, 04:54 PM

Max India Limited has announced its participation in the Arihant Capital Conference scheduled for March 11, 2026, starting at 10:00 AM. The meeting will be held virtually and involves interactions with various analysts and institutional investors. The company will utilize the Investor Presentation previously filed with the exchanges on February 20, 2026, for these discussions. Management has explicitly stated that no unpublished price-sensitive information (UPSI) will be shared during the event.

Virtual meeting scheduled for March 11, 2026, at 10:00 AM onwards.
Participation in the Arihant Capital Conference to engage with institutional investors.
Discussions to be based on the Investor Presentation uploaded on February 20, 2026.
Compliance with SEBI Regulation 30 regarding disclosure of investor meets.
No unpublished price-sensitive information (UPSI) intended to be discussed.

💡 Investors should review the February 20, 2026, investor presentation to understand the company's current trajectory, as no new material information is expected from this routine meet.

Max India Proposes ₹3 Cr Chairman Pay and 1.1 Million ESOP Pool Expansion

🟡 NEUTRAL ⭐ 6/10

MANAGEMENT 📅 20 Feb 2026, 08:08 PM

Max India Limited has issued a postal ballot notice seeking shareholder approval for two key special resolutions. The first resolution proposes an annual compensation of ₹3 crore for Non-Executive Chairman Mr. Analjit Singh for FY 2026-27, which exceeds 50% of the total remuneration for all non-executive directors. The second resolution seeks to expand the 2020 Employee Stock Option Plan (ESOP) pool by 1.1 million options, increasing the total pool to 3,789,313 options. Shareholders can participate in remote e-voting from February 21 to March 22, 2026.

Proposed annual compensation of ₹3,00,00,000 for Non-Executive Chairman Mr. Analjit Singh for FY 2026-27.
Increase in ESOP 2020 pool size by 11,00,000 options, bringing the total to 3,789,313 options.
Chairman's proposed pay exceeds 50% of the total annual remuneration payable to all Non-Executive Directors.
Remote e-voting period scheduled from February 21, 2026, to March 22, 2026, with a cut--off date of February 13, 2026.

💡 Investors should evaluate the potential equity dilution from the 1.1 million additional ESOPs and review the justification for the Chairman's compensation. It is advisable to monitor the voting results to understand institutional sentiment regarding these governance and incentive proposals.

Max India's Antara Care Homes Revenue Grows 2.4x YoY; Bed Capacity Reaches 485

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 20 Feb 2026, 04:54 PM

Max India's senior care brand, Antara, reported a strong 2.4x YoY growth in Care Homes revenue to Rs 5.0 crore for Q3FY26. The company has successfully scaled its capacity to 485 beds across NCR, Bangalore, and Chennai, while its senior residence projects in Noida and Gurugram are fully sold out. Antara is positioning itself to lead the Indian senior care market, which is projected to reach USD 33 billion by 2030. The company aims to add 1.5 million sq. ft. of senior living space annually to capitalize on the rising demand for organized senior care.

Care Homes net revenue increased 2.4x YoY to Rs 5.0 crore in Q3FY26 with an ARPOB of approximately Rs 6,500.
Operational bed capacity reached 485 beds across 4 cities, with occupancy improving to 27% in Q3FY26.
Senior residence inventory of ~650 units in Noida and Gurugram is 100% sold out, with Noida ready for possession.
AGEasy product vertical has served over 6.5 lakh customers since its 2023 launch, offering 180+ SKUs for chronic condition management.
The company targets a development pace of 1.5 million sq. ft. per year to address a market with only 1.3% current penetration.

💡 Investors should track the occupancy rates of the newly launched Care Homes in Chennai and Bangalore as a key driver for profitability. The company's ability to execute its 1.5 million sq. ft. annual expansion plan will be critical for long-term value creation in the niche senior care segment.

Max India Q3 Revenue Grows 27% to ₹49.8 Cr; Targets Consolidated Profitability by FY28

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 16 Feb 2026, 06:41 PM

Max India reported a 27% YoY increase in Q3 FY26 revenue to ₹49.8 crore, supported by strong momentum in its Antara Senior Living and Assisted Care verticals. While consolidated EBITDA remains negative at ₹29 crore due to expansion costs, the company has a clear roadmap to reach breakeven for its key business units by FY27. The residential segment is performing well with the successful launch of Estate 361 in Gurgaon, securing 100 bookings in Phase 1 within two months. Management maintains a healthy liquidity position with ₹105 crore in treasury assets to fund its growth towards consolidated profitability by FY28.

Q3 FY26 revenue increased 27% YoY to ₹49.8 crore; 9M FY26 revenue grew 19% to ₹141.3 crore.
Estate 361 Phase 1 launched in Dec '25 with 100 of 180 units already booked; management fee of ₹28.2 crore earned from Estate 360 since inception.
Assisted Care bed capacity reached 485 with occupancy improving to 27% in Q3 FY26 from 25% in Q2.
AGEasy 9M revenue grew 2.3x YoY to ₹54 crore, with exit gross margins improving to 46% in December 2025.
Company targets breakeven for Residences and AGEasy by FY27, with consolidated profitability expected in FY28.

💡 Investors should focus on the execution of the 1.5 million sq. ft. residential pipeline and the occupancy ramp-up in Assisted Care as key triggers for the FY27 breakeven target. The stock remains a strategic long-term play on India's organized senior care market.

View All MAXIND Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Consolidated revenue grew 15% YoY in H1 FY26 to INR 91.5 Cr. Antara Assisted Care Services (AACSL) revenue grew 76% (1.7x) to ~INR 44 Cr in FY25. AGEasy (launched 2023) scaled to INR 21.3 Cr in FY25 with an Annual Recurring Revenue (ARR) of INR 75 Cr. Care at Home achieved 400% growth over 4 years, reaching INR 17.23 Cr in FY25.

Geographic Revenue Split

While specific regional percentages are not disclosed, major contributions come from the Gurugram 'Estate 360' project, which achieved cumulative sales of 260 units and collected INR 239 Cr (94% efficiency), and the Dehradun facility which achieved breakeven ahead of plan with revenue at 109% of target.

Profitability Margins

AGEasy achieved a 23% contribution margin exit rate in September 2025. 64% of AGEasy products deliver a gross margin exceeding 50%. Care Homes target double-digit EBITDA margins once they reach 65-75% occupancy, typically 8-9 quarters post-launch.

EBITDA Margin

Consolidated EBITDA loss was INR 25.3 Cr in Q2 FY26 (approx -50% margin) compared to a loss of INR 15.7 Cr in Q2 FY25. FY25 consolidated EBITDA loss was INR 99.2 Cr (approx -60% margin) vs INR 34.3 Cr loss in FY24, driven by expansion costs in Care Homes and AGEasy scaling.

Capital Expenditure

The company raised INR 124.23 Cr through a rights issue in FY25 to fund AACSL growth. Invested capital in Senior Living (Residences) stood at INR 448 Cr as of September 2025. Liquidity of INR 208 Cr is earmarked for growth.

Credit Rating & Borrowing

Net debt of INR 105 Cr has been fully repaid. Finance costs increased 141% YoY to INR 4.1 Cr in Q2 FY26 from INR 1.7 Cr in Q2 FY25, reflecting increased utilization of credit for expansion before debt repayment.

⚙️ Operational Drivers

Raw Materials

Nutraceuticals (Gut Health range), senior care medical products (knee braces, diapers, nebulizers), and construction materials for senior living residences.

Import Sources

40% of sourcing for AGEasy products is currently from China to optimize gross margins.

Key Suppliers

Wellbeing Nutrition (Mumbai-based partner for Gut Health nutraceuticals).

Capacity Expansion

Targeting 500 operational beds in Assisted Care by November 2025. Planning to launch and sell 1.5 million square feet of senior residential units over the next 4 years.

Raw Material Costs

Not disclosed as a standalone percentage of revenue, but 40% sourcing from China is a key strategy to maintain the >50% gross margin seen in 64% of the AGEasy product portfolio.

Manufacturing Efficiency

Care Homes reach 40-50% occupancy within 4-5 quarters and 65-75% within 8-9 quarters. AGEasy marketing efficiency improved with RoAS (Return on Ad Spend) increasing to 2.9 in September 2025.

Logistics & Distribution

Flipkart marketplace now contributes 12-13% of AGEasy distribution.

📈 Strategic Growth

Expected Growth Rate

25%

Growth Strategy

Scaling AGEasy to reach breakeven by late FY27 or early FY28 through product expansion (14 new products in H1 FY26) and celebrity partnerships (Anupam Kher). Expanding Assisted Care footprint to 500 beds and executing a 1.5 million sq. ft. residential development pipeline.

Products & Services

Senior living residences (Estate 360), Care Homes (assisted living), Care at Home services, and AGEasy health products (nutraceuticals, mobility aids, and wellness interventions).

Brand Portfolio

Antara, AGEasy, Estate 360.

New Products/Services

Gut Health nutraceutical range launching Nov/Dec 2025 in partnership with Wellbeing Nutrition; 14 products launched in H1 FY26.

Market Expansion

Expansion of Assisted Care footprint across India; entering new markets with the AGEasy digital/product platform to reach seniors irrespective of geography.

Market Share & Ranking

Operates in a nascent market with 1.3% penetration; Max India is positioned as a first-mover in the organized 'Silver Economy' projected to reach USD 33 Bn by 2030.

Strategic Alliances

Partnership with Wellbeing Nutrition for nutraceuticals; celebrity partnerships with Anupam Kher and Hiten Tejwani for brand building.

🌍 External Factors

Industry Trends

The 'Silver Economy' is evolving from a nascent USD 13 Bn market (2024) to a projected USD 33 Bn market by 2030, driven by the rise of nuclear families and higher life expectancy. Max India is positioning itself as an integrated ecosystem (residences + care + products) to capture this 16.8% CAGR opportunity.

Competitive Landscape

Increasing competition as more players enter the rapidly evolving senior care sector, though Antara maintains high brand credibility.

Competitive Moat

Sustainable moat built through brand credibility (Max Group legacy), 4 product patents, and a specialized operational framework (800+ SOPs) that is difficult for new entrants to replicate quickly.

Macro Economic Sensitivity

High sensitivity to GDP growth and inflation, which influence consumer behavior in the premium senior care sector.

Consumer Behavior

Shift toward nuclear families and higher digital literacy among seniors is driving demand for organized home care and wellness products.

Geopolitical Risks

Trade barriers or supply chain issues with China could impact the 40% sourcing strategy for AGEasy.

⚖️ Regulatory & Governance

Industry Regulations

Subject to real estate development regulations (RERA) and healthcare service standards for Care Homes and Assisted Living facilities.

Taxation Policy Impact

Consolidated tax credit of INR 1.0 Cr reported in H1 FY26.

⚠️ Risk Analysis

Key Uncertainties

The capital-intensive nature of real estate development (INR 448 Cr invested) poses liquidity risks if project absorption slows. The 8-9 quarter timeline to EBITDA breakeven for Care Homes creates a long gestation period for profitability.